یک استراتژی برای جلوگیری از بیماری های واگیردار
ترجمه نشده

یک استراتژی برای جلوگیری از بیماری های واگیردار

عنوان فارسی مقاله: یک استراتژی برای جلوگیری از بیماری های واگیردار مشابه طغیان ۲۰۱۹-nCoV
عنوان انگلیسی مقاله: A strategy to prevent future epidemics similar to the 2019-nCoV outbreak
مجله/کنفرانس: ایمنی زیستی و سلامتی – Biosafety and Health
رشته های تحصیلی مرتبط: پزشکی
گرایش های تحصیلی مرتبط: ویروس شناسی پزشکی، پزشکی داخلی، اپیدمیولوژی، بیماری های عفونی و گرمسیری
کلمات کلیدی فارسی: کرونا ویروس جدید، ظهور بیماری، مراقبت، کاهش ریسک، امنیت زیستی بازار، ۲۰۱۹-nCoV
کلمات کلیدی انگلیسی: Novel coronavirus, Disease emergence, Surveillance, Risk reduction, Market biosecurity, 2019-nCoV
نوع نگارش مقاله: مقاله ادیتوریال (Editorial Article)
شناسه دیجیتال (DOI): https://doi.org/10.1016/j.bsheal.2020.01.003
دانشگاه: EcoHealth Alliance, New York, USA
صفحات مقاله انگلیسی: 3
ناشر: الزویر - Elsevier
نوع ارائه مقاله: ژورنال
نوع مقاله: ISI
سال انتشار مقاله: 2020
شناسه ISSN: 2590-0536
فرمت مقاله انگلیسی: PDF
وضعیت ترجمه: ترجمه نشده است
قیمت مقاله انگلیسی: رایگان
آیا این مقاله بیس است: خیر
آیا این مقاله مدل مفهومی دارد: ندارد
آیا این مقاله پرسشنامه دارد: ندارد
آیا این مقاله متغیر دارد: ندارد
کد محصول: E14557
رفرنس: دارای رفرنس در داخل متن و انتهای مقاله
فهرست مطالب (انگلیسی)

Abstract

Acknowledgements

References

بخشی از مقاله (انگلیسی)

Abstract

A novel bat-origin coronavirus emerged in Wuhan, China in December 2019 and continues to spread across China and the world. At the time of writing, a massive global response has been implemented to control the disease as it spreads from person to person. Yet the high-risk human-wildlife interactions and interfaces that led to the emergence of SARSCoV and of 2019-nCoV continue to exist in emerging disease hotspots globally. To prevent the next epidemic and pandemic related to these interfaces, we call for research and investment in three areas: 1) surveillance among wildlife to identify the high-risk pathogens they carry; 2) surveillance among people who have contact with wildlife to identify early spillover events; and 3) improvement of market biosecurity regarding the wildlife trade. As the emergence of a novel virus anywhere can impact the furthest reaches of our connected world, international collaboration among scientists is essential to address these risks and prevent the next pandemic.

The emergence of a novel coronavirus, 2019-nCoV in Wuhan December 2019 has led to a global response to the first epidemic of this decade. It has also highlighted two key issues: First, China’s rapid and efficient capacity to identify and investigate a newly emerging disease; and second, our continued global vulnerability to epidemics and pandemics. From the date of the first cluster of cases admitted to a local hospital on December 27, 2019, Chinese scientists identified this disease as a new syndrome, discovered the pathogen as the cause, and reported its genetic sequence to the world in less than 14 days [1,2]. At the time of writing, we have detailed information on its relationship to other bat coronaviruses, many of which were discovered in a collaboration among EcoHealth Alliance, the Wuhan Institute of Virology, and Duke NUS [3]. We also have data from experimental cell line infections [4], on the clinical findings [5], the epidemiology of viral transmission [6], and on its spread to other countries. These rapid and successful results are a resounding endorsement of China’s emergence as a 21st Century scientific superpower, and of a country with a modern and efficient public health system, technically supported by the China CDC with a system of Provincial and City CDCs that are trained in effective outbreak investigation and control [7].